| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kaushal Mohit | Director | C/O THE ONCOLOGY INSTITUTE, 18000 STUDEBAKER RD, SUITE 800, CERRITOS | /s/ Mark Hueppelsheuser, Attorney-in-Fact for Mohit Kaushal | 24 Nov 2025 | 0001683021 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOI | Common Stock | Award | $0 | +50,926 | +29% | $0.000000 | 228,179 | 20 Nov 2025 | Direct | F1 |
| transaction | TOI | Common Stock | Award | $0 | +40,123 | +18% | $0.000000 | 268,302 | 20 Nov 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date. |
| F2 | Represents restricted stock units that were fully vested upon grant. |